The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS | COM | 00430H102 | 1,919 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 12,717 | 113,500 | SH | SOLE | 113,500 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,823 | 29,100 | SH | SOLE | 29,100 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 10,477 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
| BIOLINERX LTD | COM | 09071M106 | 405 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 798 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 3,760 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 2,896 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
| CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 1,811 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 11,868 | 504,800 | SH | SOLE | 504,800 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 32,409 | 805,000 | SH | SOLE | 805,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC. | COM | 189464100 | 7,840 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 4,344 | 1,724,000 | SH | SOLE | 1,724,000 | 0 | 0 | ||
| EVOKE PHARMA INC | COM | 30049G104 | 1,416 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 5,231 | 191,338 | SH | SOLE | 191,338 | 0 | 0 | ||
| FLAMEL TECHNOLOGIES SA | COM | 338488109 | 3,512 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 3,204 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 4,559 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 5,931 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
| HORIZON PHARMA PLC | COM | G4617B105 | 2,836 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 4,200 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 5,165 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 4,383 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 4,301 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,005 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| ONCOTHYREON INC | COM | 682234108 | 3,800 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 4,487 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 3,084 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| PHARMACYCLICS INC | COM | 716933106 | 10,392 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 11,261 | 920,000 | SH | SOLE | 920,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 2,905 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 1,690 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
| TETRAPHASE PHARMACEUTICALS INC | COM | 88165N105 | 7,533 | 189,700 | SH | SOLE | 189,700 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 3,000 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICALS INC | COM | 90400D108 | 4,660 | 106,200 | SH | SOLE | 106,200 | 0 | 0 | ||
| VERSARTIS INC | COM | 92529L102 | 5,276 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||